News By Tag
News By Place
Zuventus Healthcare Wins prestigious India’s Most Valuable Revolutionary Pharma Company Award
India’s fastest growing Anti-Infectives Formulation Major & The Leader in branded formulation market was voted by the Network 7 Media Group Jury for sustained growth momentum, financial stability, corporate HR
India’s fastest growing Anti-Infectives Formulation Major & The Leader in branded formulation market was voted by the Network 7 Media Group Jury for sustained growth momentum, financial stability, corporate HR & the Breakthrough Innovations In the New Product Launches in the fiercely competitive Indian Formulation Market
Saturday,3rd January 2014, Mumbai, Maharashtra : Mumbai based Zuventus Healthcare Ltd, The leader in cancer care products, and pain management and wound care therapeutics founded in 2002 and is based in Mumbai, operating as a subsidiary of Emcure Pharmaceuticals Limited received a rare distinction at the prestigious 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Power Brand Awards 2014 by receiving the coveted India’s Most Valuable Revolutionary Pharma Company Award by the Pharmaleaders jury for sustained growth momentum, financial stability, corporate HR & the Breakthrough Innovations In the New Product Launches in the fiercely competitive Indian Formulation Market. A joint venture of Emcure Pharmaceuticals Ltd & backed by its strengths of R&D, quality & Innovative Technologies, Zuventus Healthcare provide Innovative therapies in the field of health care. The Company is known for a strong marketing network with over 3000 field force with a strong product basket is the most watched company for making speedy progress within a short span of time in the fiercely competitive domestic formulation market. Presently having a 600 crore turnover, Zuventus Healthcare aims to achieve a 1000 Crore mark by the year 2016. Speaking to Pharmaleaders Mr. Prakash Guha, MD & CEO of Zuventus Healthcare Limited said “ The Award signifies Zuventus Healthcare commitment to healthcare innovations & Zuventus Healthcare continued focus on manufacturing & R &D field as a major areas of operation, We understand that Pharma market in india is a tough task where brand building is a key & Zuventus is always believed to make the Brands Bigger & acceptable to the medical profession. Rather than acquisition, Zuventus has always built its homegrown brands & made it big, we are the very few company which believes in empowerment of team work & professional growth. I am sure with a dedicated sales foprce & a strong R & D backing, Zuventus Healthcare will emerge out as a top 10 player in the Indian market soon.”. Zuventus is a pulsating Company that believes in employee’s talents to be honed, achievements to be valued and recognized. People at Zuventus are entrusted with responsibilities and are encouraged to actively contribute to the long term sustainable business growth in this highly competitive era.HR core value i.e ‘TO CARE’ lies in nurturing the employees from the day of joining. Our business dynamics offers employees with opportunities to acquire the desired functional goals, enhancement of people managements skills and facilitating the decision making power. Thus Zuventus is a “People-Centric”
Crossing the enviable 100 Cr turn over mark in just 18 months of operations, Building Mega brands which made it into Top 300 industry brands in less than 5 years of our existence, Achieving leadership positions for some brands displacing even well entrenched MNC brands are some of the top achievements. Zuventus is driven by a team of professionals with exceptional performance record in previous assignments. Naturally there was no dearth of cZuventus Healthcare age to set challenging goals and achieving them through conviction and confidence. What makes Zuventus Healthcare unique was slew of milestones, perhaps even beyond imagination of most, if not all pharma players. Zuventus Healthcare made a All India Launch with 400 field personnel (July, 2002). Zuventus Healthcare is the fastest to cross ORG-IMS reflections of 100 Cr., 200 Cr. and now even 600 Cr. mark. Zuventus Healthcare’s Launch of speciality focused divisions for effective penetration in multiple specialties and market segments.
Ø Generia & Institutions:
Ø Building leader brands: (SZuventus Healthcare ce: ORG-IMS)
Ø Successful entry into exciting field of biotechnology – Enoxarin, Eporise, Peglast.
Ø Joining hands with global giants and entry into the field of vaccines: Sanofi Pasteur – Verorab.
Ø Partnership with MNCs for exciting cutting edge products
Zuventus Healthcare has been marketing Gutclear containing Lactilol from Dupont (Danisco) with their technical support since past 4 years. It soon to be launched Dupont (Danisco) probiotic Restore II under Zuventus own brand name Florestore. Launching of ‘first time in India’ molecules with unique mode of action : Troxip (Troxipide), Lafaxid (Lafutidine)
Network 7 Media Group